Stock PSQ PACIFIC SMILES GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pacific Smiles Group Limited

Equities

PSQ

AU000000PSQ9

Healthcare Facilities & Services

Market Closed - Australian S.E.
Other stock markets
 01:56:15 2024-05-01 am EDT 		5-day change 1st Jan Change
1.875 AUD +0.27% Intraday chart for Pacific Smiles Group Limited +14.33% +28.42%
Apr. 29 National Dental Care to Acquire Pacific Smiles Group via Scheme of Arrangement MT
Apr. 29 Australian dental centres operator Pacific Smiles backs $198 mln bid from NDC RE

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 177.8 241 430.9 287.2 216.2 298.4 - -
Enterprise Value (EV) 1 187.9 310.9 420.9 293.9 206.6 277.6 272.8 270.2
P/E ratio 20.5 x 37.4 x 32.9 x -64.3 x 90.3 x 45.6 x 37.1 x 28.3 x
Yield 4.96% 1.53% 0.89% - 1.93% 2.03% 2.34% 2.99%
Capitalization / Revenue 1.46 x 2.01 x 2.81 x 2.06 x 1.31 x 1.61 x 1.5 x 1.39 x
EV / Revenue 1.54 x 2.59 x 2.75 x 2.11 x 1.25 x 1.5 x 1.37 x 1.26 x
EV / EBITDA 8.24 x 13.2 x 12.7 x 26 x 8.57 x 9.94 x 8.63 x 7.44 x
EV / FCF 41.4 x 16.8 x 31.6 x -53.6 x 6.93 x 19.8 x 68.2 x 45 x
FCF Yield 2.42% 5.94% 3.17% -1.87% 14.4% 5.04% 1.47% 2.22%
Price to Book 4.33 x 6.48 x 7.05 x 4.88 x 3.53 x 4.82 x 4.69 x 4.48 x
Nbr of stocks (in thousands) 151,993 153,516 159,582 159,582 159,582 159,582 - -
Reference price 2 1.170 1.570 2.700 1.800 1.355 1.870 1.870 1.870
Announcement Date 8/21/19 8/19/20 8/17/21 8/16/22 8/23/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 122.2 120.1 153.2 139.5 165.3 185 198.9 214.2
EBITDA 1 22.8 23.5 33.1 11.3 24.11 27.92 31.61 36.32
EBIT 1 13.4 12.5 21 -3.9 7.7 10.4 12.65 16.28
Operating Margin 10.97% 10.41% 13.71% -2.8% 4.66% 5.62% 6.36% 7.6%
Earnings before Tax (EBT) - - - -6.537 3.923 - - -
Net income 1 8.6 6.383 12.95 -4.531 2.421 6.337 7.585 10.27
Net margin 7.04% 5.32% 8.46% -3.25% 1.46% 3.42% 3.81% 4.8%
EPS 2 0.0570 0.0420 0.0820 -0.0280 0.0150 0.0410 0.0504 0.0662
Free Cash Flow 1 4.54 18.47 13.34 -5.483 29.8 14 4 6
FCF margin 3.72% 15.38% 8.71% -3.93% 18.03% 7.57% 2.01% 2.8%
FCF Conversion (EBITDA) 19.91% 78.6% 40.3% - 123.62% 50.14% 12.65% 16.52%
FCF Conversion (Net income) 52.79% 289.36% 102.97% - 1,231.02% 220.93% 52.73% 58.41%
Dividend per Share 2 0.0580 0.0240 0.0240 - 0.0262 0.0379 0.0438 0.0558
Announcement Date 8/21/19 8/19/20 8/17/21 8/16/22 8/23/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2023 S1 2023 S2 2024 S1
Net sales 1 68.3 51.76 78.4 74.78 66.93 81.6 83.71 90
EBITDA 1 12.9 10.6 21.2 11.9 5 9.148 14.96 13.88
EBIT 1 7.5 5 16.91 4.09 -2.4 1.3 12.99 5.7
Operating Margin 10.98% 9.66% 21.57% 5.47% -3.59% 1.59% 15.52% 6.33%
Earnings before Tax (EBT) 6.3 3.071 - - -3.62 - - -
Net income 1 4.1 2.283 9.789 3.164 -2.186 0.222 2.199 4.407
Net margin 6% 4.41% 12.49% 4.23% -3.27% 0.27% 2.63% 4.9%
EPS - - - - - 0.001000 - -
Dividend per Share 2 - - - - - 0.003500 0.0227 0.0210
Announcement Date 2/19/20 8/19/20 2/16/21 8/17/21 2/15/22 2/21/23 8/23/23 2/26/24
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 10 69.9 - 6.7 - - - -
Net Cash position 1 - - 9.95 - 9.6 20.8 25.6 28.2
Leverage (Debt/EBITDA) 0.4407 x 2.975 x - 0.5925 x - - - -
Free Cash Flow 1 4.54 18.5 13.3 -5.48 29.8 14 4 6
ROE (net income / shareholders' equity) 21.5% 20.8% 28.6% -7.55% 6.99% 12.1% 13.4% 16.6%
ROA (Net income/ Total Assets) 11.2% 7% 8.39% - 2.21% 3.5% 4% 4.8%
Assets 1 76.92 91.2 154.4 - 109.5 181.1 189.6 214
Book Value Per Share 2 0.2700 0.2400 0.3800 0.3700 0.3800 0.3900 0.4000 0.4200
Cash Flow per Share 2 0.1400 0.1900 0.2500 0.1100 0.2600 0.1600 0.1700 0.2000
Capex 1 16.6 10.1 25.6 23.4 11.1 7.86 18.4 19.7
Capex / Sales 13.62% 8.42% 16.71% 16.76% 6.7% 4.25% 9.25% 9.22%
Announcement Date 8/21/19 8/19/20 8/17/21 8/16/22 8/23/23 - - -
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Pacific Smiles Group Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
1.87 AUD
Average target price
1.508 AUD
Spread / Average Target
-19.39%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
PACIFIC SMILES GROUP LIMITED Stock Pacific Smiles Group Limited
+28.42% 194M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.25% 85.35B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+14.46% 81.95B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+9.37% 28.99B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-11.40% 16.98B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.36% 16.85B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+0.22% 15.35B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+4.32% 12.42B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-2.34% 11.88B
DAVITA INC. Stock DaVita Inc.
+32.69% 12.19B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. PSQ Stock
  4. Financials Pacific Smiles Group Limited